drugset / Trial / NCT04523363

Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes

NCT04523363

Phase 4 Withdrawn Gianna Wilkie
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to assess if metformin reduces adverse outcomes associated with prediabetes in pregnancy. Our hypothesis is that pregnant women with prediabetes who are treated with metformin will show a greater reduction in large for gestational age infants at birth compared to women treated with the standard of care.

Timeline

Start
2025-06-01
Primary completion
2026-06-30
Completion
2026-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral

Indications